DSHNHL 2006-1A (AATT)

Autologous or allogeneic transplantation following conventional chemotherapy in younger patients (18-60 yrs.) with mature (peripheral) T-cell lymphoma (Acronym: AATT).
The aim is to investigate whether the event-free survival of patients with primary diagnosis of mature (peripheral) T-cell lymphoma can be improved by allogeneic hematopoietic stem cell transplantation after conditioning with FBC compared to autologous peripheral blood stem cell transplantation after high dose therapy with BEAM. Conventional treatment before high dose therapy will be the same for both treatment arms (4 cycles of CHOEP-14 followed by one cycle of DHAP).

Zuständig für diese Studie:

Kompetenzzentrum Hamburg

Asklepios Klinik St. Georg
Abteilung für Hämatologie und Stammzelltransplantation
Lohmühlenstraße 5
20099 Hamburg
Tel.: +49 (0) 40-18 18 85-2005
Fax: +49 (0) 40-18 18 85-4226